Watchlist

Watchlist
AnaptysBio, Inc. (ANAB)
When The Bulls Growl And The Bears Moo - Stock Market Outlook 2018
Market Pulse The year 2017 will be remembered as the year when the Bulls Growled and the Bears Mooed. A year when stock market volatility for the first time ever subsided to a level below that of bonds. A year when the market refused to relent to the historical valuation templates and hand…
Stocks to watch next week
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. More news on: Apple Inc., Amazon.com, Inc., Intel Corporation, Tech stocks news, …
Jonathan Faison Positions For 2018: Faster FDA Approval, Emerging Sector In China Bode Well For Biotech Next Year
An 11-year Seeking Alpha member, author Jonathan Faison focuses on discovering under-the-radar stocks and alpha-generating ideas for his readers. Operating primarily in the biotech sector, his specialty is looking specifically for opportunities to achieve high percentage gains within a year's …
Your Daily Pharma Scoop: Valeant Still Risky, Onconova Signs Agreement, Array Biopharma Announces Collaboration
Content Analysis of coverage: VRX Stocks in the news: ONTX, RGNX, ARRY Analyst Ratings Insider Sales Insider Purchases Earnings Report Secondary Offerings Earnings Calendar Trade Idea for the Day (for TPT subscribers only) Subscriber Questions & Ans…
Biotech Bonanza: Biotech Stocks To Keep Shining In 2018
Biotechs have had a good year so far. Not a blistering rise, but nonetheless a steady rise. Of course, one expects even stronger performance on a relative basis from a higher-risk sector, particularly when the overall market continues to record all-time highs. Perhaps such out-performance is r…
Nasdaq Biotech Index: 54 to be added, 15 removed
Changes will become effective prior to the open next Monday. ETF: IBB More news on: iShares Nasdaq Biotechnology ETF, Arbutus Biopharma Corp, Aclaris Therapeutics, Healthcare stocks news, News on ETFs, Read more …
Aimmune Therapeutics: Upside Into Q1 Data And Beyond
Shares of Aimmune Therapeutics (AIMT) have risen by 75% since my late February article, where I called the stock a "solid Runner of the Year candidate." AIMT data by YCharts Keys to the original bullish thesis included the following: I was optimistic on oral biologic drug candidate…
Medical Stocks: Investing For 2018
2017 has turned out to be a good year for medical stocks, with strong gains in biopharmaceuticals, medical devices, diagnostics and HMOs. This can be attributed to a strong overall stock market, a quieting of concerns regarding drug pricing, an unchanged ACA and an underlying 6% growth rate …
AnaptysBio (ANAB) Presents At Jefferies 2017 London Healthcare Conference - Slideshow
The following slide deck was published by AnaptysBio in conjunction with this Read more …
AnaptysBio (ANAB) Presents At Stifel 2017 Healthcare Conference - Slideshow
The following slide deck was published by AnaptysBio in conjunction with this Read more …
Premarket analyst action - healthcare
Nektar Therapeutics (NASDAQ: NKTR ) initiated with Buy rating and $35 (16% upside) price target by Canaccord Genuity. More news on: Nektar Therapeutics, AnaptysBio, Acorda Therapeutics, Inc., Healthcare stocks news, Read more …
AnaptysBio, Inc. (ANAB)